Clinical trial
Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer
NCT01671332
Study timeline
Study start (actual)2012-06-01Date precision: month
Registry last updated2020-05-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Carcinoma, Non Small Cell Lungunresolved
Interventions
Sponsors & collaborators
University of Wisconsin, Madisonlead sponsor
Medical College of Wisconsincollaborator
Optimum Therapeutics, LLCcollaborator
Ohio State Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01671332 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.